De-risking hydrogenation:


dan stark

de risking hydrogenation

Hydrogen gas is one of the most atom efficient and cost-effective reagents available in synthetic chemistry. Molecular hydrogen (H2), typically in the presence of a metal catalyst, is used in two core methodologies: hydrogenation reactions, where H2 is added to a molecule, and hydrogenolysis, the use of H2 to break a chemical bond with subsequent addition to resulting molecular fragments.

Both reaction methodologies have seen high utility and impact in synthetic chemistry going back as far as the 19th century and remain central to modern pharmaceutical manufacturing.1 They are essential for transforming a wide range of functional groups, including:

icon reduction

Reduction and saturation of alkynes, alkenes, nitroaromatics, nitriles

icon reduction

Reductive amination reactions converting imines to amines

icon reduction

Deprotection of benzyl or carbamate protected nitrogen and oxygen groups

Many important chemical motifs found in active pharmaceutical ingredients (APIs) are accessible through these methodologies, making hydrogen gas a must-have in the toolbox of chemists and CDMOs alike. However, these reactions create several challenges that must be carefully addressed in order to maximise their safety and efficacy.

hydrogenation challenges

Though the use of hydrogen gas in synthetic chemistry has a variety of advantages, there are a multitude of factors that organisations must consider to ensure the safe and efficient application of these methods. Let’s take a closer look at some of these key considerations.

Temperature and pressure control

Hydrogen gas delivery method

Catalyst screening and selection

Scale-up assessment 

Process safety and hazard evaluation 

Reactor cleaning

Post-reaction catalyst removal

Product stability and purity

hydrogenation or hydrogenolysis

  • Pd/C
  • PdOH/C
  • Pt/C
  • Raney Ni
  • Lindlar’s Catalyst
  • Wilkinson’s Catalyst
  • Ru/Rh/Mn/Fe-based catalysts

At Sterling, we have over 50 years of experience in large-scale hydrogenations using hydrogen gas, with multiple cGMP API manufacturing assets across our global network of facilities. Our capabilities and equipment range from 10L to 6,300L in volume and up to 69 bar in pressure capability. Many of our assets are also capable of handling other pressure reactions and hazardous gases.

We believe that hydrogen reaction success is achieved by building a solid foundation of scientific, engineering and safety excellence from the very start of development. With a suite of lab-scale pressure reactors ranging from 25mL to 5L, we can develop the process in equipment that closely mimics the intended large-scale assets, reducing scale-up risk substantially and allowing us to thoroughly optimise the process for scale-up.

All our hydrogenation reactions progress through comprehensive hazard evaluation studies and risk assessments to ensure that all potential adverse events are proactively considered and mitigated with robust safety procedures and engineering controls. We apply our proven track record in handling hazardous gases and pyrophoric catalysts at scale to de-risk each and every reaction involving hydrogen.

If you’re interested in learning more about how we can support your hydrogenation or hydrogenolysis reaction, speak to one of our experts today.

What is hydrogenation used for in API manufacturing?

What is the difference between hydrogenation and hydrogenolysis?

What catalysts are commonly used in hydrogenation?

How does hydrogen gas present risks in chemical reactions? 

What are some best practices to prepare hydrogenation reactions for scale-up? 

What sets Sterling’s hydrogenation and hydrogenolysis capabilities apart?

How does Sterling handle customer projects with more limited hydrogenation development?

icon service

icon service

icon article

1. List, G. & Jackson, M.A. The Battle Over Hydrogenation. AOCS. July 23, 2019. Retrieved from https://www.aocs.org/resource/the-battle-over-hydrogenation-1903-1920/